Cyclopharm Limited (AU:CYC) has released an update.
Cyclopharm Limited has announced the final details of its share buy-back program, providing key information such as the buy-back type and the class of securities involved. Shareholders of Cyclopharm Limited should note that the buy-back will involve ordinary fully paid shares, underlining the company’s strategic efforts to manage capital.
For further insights into AU:CYC stock, check out TipRanks’ Stock Analysis page.